Century Therapeutics Inc
NASDAQ:IPSC
Century Therapeutics Inc
NASDAQ:IPSC
Price:
3.04 USD
-2.56%
Market Closed
Updated:
May 26, 2024
Section:
Relative Value
The Relative Value of one
IPSC
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.04 USD,
Century Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IPSC Relative Value
HIDDEN
Valuation Multiples
Multiples Across Competitors
IPSC Competitors Multiples
Century Therapeutics Inc Competitors
Century Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Century Therapeutics Inc
NASDAQ:IPSC
|
251.9m USD | 183.4 | -1.9 | -0.5 | -0.4 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
277.3B USD | 5.1 | 46.6 | 13.1 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
164.1B USD | 5.6 | 43.6 | 18.4 | 30.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118B USD | 11.6 | 29.4 | 24.7 | 25.8 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108.5B USD | 8.3 | 28.1 | 22.8 | 25.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.7B AUD | 6.3 | 36.4 | 22 | 27.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
81.8B USD | 3 | 169.1 | 8.6 | 11.3 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.8B USD | 12.4 | -10.7 | -12.3 | -10.9 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
31.7B USD | 3.3 | 27.2 | 13.9 | 17.4 | |
| KR |
|
Celltrion Inc
KRX:068270
|
37.3T KRW | 16.1 | 94.9 | 47.8 | 79.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
